AMGEN INC is 24.9x more valuable than REPLIGEN CORP by market capitalization ($183.41 B vs $7.38 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | RGEN | AMGN |
|---|---|---|
| Market cap | $7.38 B | $183.41 B |
| US-listed rank | #1115 | #79 |
| Revenue (latest FY) | $141.24M | $36.75B |
| Net income (latest FY) | $48.89M | $7.71B |
| Net margin | 34.6% | 21.0% |
| P/E (trailing FY) | 150.9 | 23.8 |
| SEC filings | 1,331 | 1,011 |
AMGEN INC is 24.9x more valuable than REPLIGEN CORP by market capitalization ($183.41 B vs $7.38 B).
In their latest fiscal years, REPLIGEN CORP reported $141.24M in revenue while AMGEN INC reported $36.75B.
Full pages: REPLIGEN CORP and AMGEN INC, or browse the full rankings.